World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
131
Citations
115813
World Ranking
2340
National Ranking
90

Overview

Joseph M. Connors is affiliated with the University of British Columbia in Canada and has contributed extensively to research in the field of Medicine. Their primary areas of study include Pathology and Forensic Medicine, Oncology, Genetics, Pulmonary and Respiratory Medicine, and Neurology.

Their research focuses heavily on lymphoma and related hematologic cancers. Major topics covered by their work encompass Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Lung Cancer Treatments and Mutations, Viral-associated Cancers and Disorders, CNS Lymphoma Diagnosis and Treatment, CAR-T Cell Therapy Research, and Multiple and Secondary Primary Cancers.

Joseph M. Connors has published in several prominent venues, with frequent publications in:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia & lymphoma/Leukemia and lymphoma
  • Blood Advances
  • Journal of Clinical Oncology

Frequent coauthors include:

  • Kerry J. Savage
  • Laurie H. Sehn
  • Diego Villa
  • David W. Scott
  • Alina S. Gerrie

Notable recent papers by or including Joseph M. Connors are:

  • Hodgkin lymphoma, 2020, Nature Reviews Disease Primers
  • Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma, 2022, New England Journal of Medicine
  • Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial, 2021, The Lancet Haematology
  • Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study, 2020, Blood
  • Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma, 2020, Blood Advances

Best Publications

  • Circos: An information aesthetic for comparative genomics

    Martin I Krzywinski;Jacqueline E Schein;Inanc Birol;Joseph Connors

  • A predictive model for aggressive non-Hodgkin's lymphoma

    M. A. Shipp;D. P. Harrington;J. R. Anderson;J. O. Armitage

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

    Christine P. Hans;Dennis D. Weisenburger;Timothy C. Greiner;Randy D. Gascoyne

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma

    James O. Armitage

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

    Morin Rd;Johnson Na;Severson Tm;Mungall Aj

  • Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

    Ryan D Morin;María Méndez-Lago;Andrew J Mungall;Rodrigo Goya

  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

    Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson

  • Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

    Anas Younes;Ajay K. Gopal;Scott E. Smith;Stephen M. Ansell

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

    Laurie H. Sehn;Brian Berry;Mukesh Chhanabhai;Catherine Fitzgerald

  • Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

    Christian Steidl;Tang Lee;Sohrab P. Shah;Pedro Farinha

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

    Laurie H. Sehn;Jane Donaldson;Mukesh Chhanabhai;Catherine Fitzgerald

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

Frequent Co-Authors

Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Kerry J. Savage
Kerry J. Savage University of British Columbia
Christian Steidl
Christian Steidl University of British Columbia
Marco A. Marra
Marco A. Marra University of British Columbia
Ryan D. Morin
Ryan D. Morin Simon Fraser University
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Douglas E. Horsman
Douglas E. Horsman University of British Columbia
Elias Campo
Elias Campo University of Barcelona
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Andreas Rosenwald
Andreas Rosenwald University of Würzburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring pathways in healthcare isn’t limited to traditional medicine degrees. Many students consider alternative or supportive roles, often accessible through flexible online programs. For those looking to enter nursing from a non-nursing background, consider direct entry online msn programs, designed to accelerate your transition into advanced nursing careers.

If you’re seeking quicker or less competitive routes into nursing, you can research easy nursing programs to get into for more accessible admission requirements. Some programs even allow you to skip standardized tests. To better understand your options, check whether do i need to take the teas test for lpn is required at your preferred schools.

For those interested in administrative roles, online medical billing and coding with financial aid programs offer a practical entry point into healthcare, often with less cost and time investment. These options make healthcare careers more accessible for students from all backgrounds.

Best Scientists Citing Joseph M. Connors

Trending Scientists

Recently Published Articles